He who pays the piper calls the tune: the role of the industry sponsor in acute stroke trials
| Autor: | Michael Bozik |
|---|---|
| Rok vydání: | 2003 |
| Předmět: |
medicine.medical_specialty
Clinical Trials as Topic Drug Industry business.industry Public health Principal (computer security) Public relations medicine.disease Clinical disease Clinical trial Stroke Neurology Drug development Acute Disease medicine Humans cardiovascular diseases Neurology (clinical) business Neuroscience health care economics and organizations Acute stroke Pharmaceutical industry |
| Zdroj: | European neurology. 49(2) |
| ISSN: | 0014-3022 |
| Popis: | Ischemic stroke remains a complex neurobiological and clinical disease, and stroke drug development remains time consuming and costly. In addressing these challenges, the pharmaceutical industry has a principal responsibility to ensure that the acute stroke trials it sponsors are ethically conducted, scientifically sound and satisfy global regulatory requirements. The industry must also be a leader in promoting the innovative and effective partnerships between the public, private and academic sectors that are necessary if new therapies for patients with acute stroke are to be developed. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|